Early post‐liver transplant use of direct‐acting antivirals in naive and <scp>NS5A</scp> inhibitor‐experienced <scp>HCV</scp> patients-Reference-Cited by-同舟云学术

Early post‐liver transplant use of direct‐acting antivirals in naive and NS5A inhibitor‐experienced HCV patients

Published:2022-12-16 Issue:3 Volume:30 Page:201-208
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:Journal of Viral Hepatitis

Author:

Saracco Margherita¹^ORCID,Tandoi Francesco²^ORCID,Maletta Francesca³^ORCID,Balagna Roberto⁴,Romagnoli Renato²^ORCID,Martini Silvia¹^ORCID

Affiliation:

1. Gastrohepatology Unit Azienda Ospedaliero‐Universitaria Città della Salute e della Scienza di Torino Turin Italy

2. Liver Transplantation Center and General Surgery 2U Azienda Ospedaliero‐Universitaria Città della Salute e della Scienza di Torino Turin Italy

3. Pathology Unit Azienda Ospedaliero‐Universitaria Città della Salute e della Scienza di Torino Turin Italy

4. Anesthesia and Intensive Care Unit 2 Azienda Ospedaliero‐Universitaria Città della Salute e della Scienza di Torino Turin Italy

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvh.13782

Reference34 articles.

1. Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation

2. Portrait of Regional Trends in Liver Transplantation for Nonalcoholic Steatohepatitis in the United States

3. World Health Organization.Hepatitis C.2021.https://www.who.int/news‐room/fact‐sheets/detail/hepatitis‐c

4. World Health Organization.Global health sector strategy on viral hepatitis 2016–20212016.http://apps.who.int/iris/bitstream/10665/246177/1/WHO‐HIV‐2016.06‐eng.pdf

5. Impact of COVID-19 on global HCV elimination efforts